|
||
|
| Home |  |
Firm Description | |
Sectors Covered | |
Completed Transactions | |
Testimonials | |
Principals | |
M&A Report and Publications |
|
Contact Us | |
| Acquiring Party | Bridgepoint Capital, a European private equity firm. |
|---|---|
| Transferring Party | Gambro Healthcare, the dialysis care services division of Swedish Gambro Group, the global medical technology company. |
| Sector | Medical Services |
| Date | May 7, 2007 |
| Analysis Gambro is the second largest provider of dialysis care services in Europe with 155 clinics in 14 countries serving 12,000 patients and with ancillary businesses in South America and Australia. A growing business in a fragmented sector with significant potential for further growth due to increased incidence of diabetes, hypertension, obesity and other conditions. Deal value said to be more than $820m, on expected sales of $334m (2.4x) and EBITDA of $65m (12.6x). | |
The Walden Group is a leading healthcare investment banking firm specializing in mergers, acquisitions and strategic transactions. It also invests its own funds and, together with its expert operational partners, provides value-added services to help special companies reach critical milestones. This information is copyright © 2004-2007 The Walden Group, Inc. This information is provided as a service to the public but remains the intellectual property of The Walden Group, Inc and may not be reproduced in any manner without the written permission of The Walden Group, Inc. The information contained in the transactions table was derived from publicly available and other sources. Transaction analysis and other information are based, in part, upon public comments, Walden Group research and judgments, and reporting and research of others. The information is not intended to be relied upon as pronouncements by the transaction participants or for any other reason. | |